John Nicholson
2017
In 2017, John Nicholson earned a total compensation of $7.8M as Senior Vice President and Chief Operating Officer at Nektar Therapeutics, a 182% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $547,575 |
|---|---|
| Option Awards | $3,672,084 |
| Salary | $625,800 |
| Stock Awards | $2,958,794 |
| Other | $26,907 |
| Total | $7,831,160 |
Nicholson received $3.7M in option awards, accounting for 47% of the total pay in 2017.
Nicholson also received $547.6K in non-equity incentive plan, $625.8K in salary, $3M in stock awards and $26.9K in other compensation.
Rankings
In 2017, John Nicholson's compensation ranked 984th out of 14,666 executives tracked by ExecPay. In other words, Nicholson earned more than 93.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 984 out of 14,666 | 93rd |
Division Manufacturing | 334 out of 5,770 | 94th |
Major group Chemicals And Allied Products | 86 out of 2,074 | 96th |
Industry group Drugs | 57 out of 1,730 | 97th |
Industry Pharmaceutical Preparations | 47 out of 1,329 | 97th |
Source: SEC filing on April 30, 2018.
Nicholson's colleagues
We found four more compensation records of executives who worked with John Nicholson at Nektar Therapeutics in 2017.
2017
Howard Robin
Nektar Therapeutics
Chief Executive Officer
2017
Gil Labrucherie
Nektar Therapeutics
Chief Financial Officer
2017
Stephen Doberstein
Nektar Therapeutics
Senior Vice President and Chief Research and Development Officer
2017
Maninder Hora
Nektar Therapeutics